Combinatorial Effect of DCA and Let-7a on Triple-Negative MDA-MB-231 Cells: A Metabolic Approach of Treatment

被引:15
|
作者
Sharma, Praveen [1 ]
Singh, Sandeep [1 ]
机构
[1] Cent Univ Punjab, Bathinda, Punjab, India
关键词
DCA; OXPHOS; miRNA; breast cancer; metabolic reprogramming; mitogenesis; DICHLOROACETATE INDUCES APOPTOSIS; METASTATIC BREAST-CANCER; GROWTH-FACTOR RECEPTOR; INHIBITORS; MIGRATION; MICRORNA; MITOPHAGY; AUTOPHAGY;
D O I
10.1177/1534735420911437
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dichloroacetate (DCA) is a metabolic modulator that inhibits pyruvate dehydrogenase activity and promotes the influx of pyruvate into the tricarboxylic acid cycle for complete oxidation of glucose. DCA stimulates oxidative phosphorylation (OXPHOS) more than glycolysis by altering the morphology of the mitochondria and supports mitochondrial apoptosis. As a consequence, DCA induces apoptosis in cancer cells and inhibits the proliferation of cancer cells. Recently, the role of miRNAs has been reported in regulating gene expression at the transcriptional level and also in reprogramming energy metabolism. In this article, we indicate that DCA treatment leads to the upregulation of let-7a expression, but DCA-induced cancer cell death is independent of let-7a. We observed that the combined effect of DCA and let-7a induces apoptosis, reduces reactive oxygen species generation and autophagy, and stimulates mitochondrial biogenesis. This was later accompanied by stimulation of OXPHOS in combined treatment and was thus involved in metabolic reprogramming of MDA-MB-231 cells.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells
    Castellanos-Esparza, Yessica Cristina
    Wu, Shuang
    Huang, Limin
    Buquet, Catherine
    Shen, Rong
    Sanchez-Gonzalez, Berenice
    Latorre, Ethel Awilda Garcia
    Boyer, Olivier
    Varin, Remi
    Jimenez-Zamudio, Luis Antonio
    Janin, Anne
    Vannier, Jean-Pierre
    Li, Hong
    Lu, He
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (04) : 1246 - 1254
  • [2] Anti-Proliferative Effect of 5-Heptadecylresorcinol on MDA-MB-231 Triple-Negative Breast Cancer Cells
    Xie M.
    Liu J.
    Zhu K.
    Sun B.
    Wang J.
    Journal of Food Science and Technology (China), 2019, 37 (06): : 53 - 63
  • [3] Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel
    Simu, Sebastian
    Marcovici, Iasmina
    Dobrescu, Amadeus
    Malita, Daniel
    Dehelean, Cristina Adriana
    Coricovac, Dorina
    Olaru, Flavius
    Draghici, George Andrei
    Navolan, Dan
    MOLECULES, 2021, 26 (09):
  • [4] Ectophosphatase activity in the triple-negative breast cancer cell line MDA-MB-231
    Lacerda-Abreu, Marco A.
    Russo-Abrahao, Thais
    Leite Tenorio Aguiar, Raissa
    Monteiro, Robson de Queiroz
    Rumjanek, Franklin D.
    Meyer-Fernandes, Jose R.
    CELL BIOLOGY INTERNATIONAL, 2021, 45 (02) : 411 - 421
  • [5] Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro
    Abrahams, Beynon
    Gerber, Anthonie
    Hiss, Donavon Charles
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [6] Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells
    Amaral, Ines
    Silva, Claudia
    Correia-Branco, Ana
    Martel, Fatima
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 94 - 101
  • [7] MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells
    Li, Gang
    Yang, Mei
    Zuo, Li
    Wang, Mei-Xing
    ONCOLOGY LETTERS, 2018, 15 (06) : 9934 - 9940
  • [8] High Thermosensitivity of MDA-MB-231 Cells as a Prerequisite for Thermoradiosensitization of Triple-Negative Breast Cancer in Clinical Practice
    Yakimova, A. O.
    Kabakov, A. E.
    BIOLOGY BULLETIN, 2023, 50 (12) : 3293 - 3300
  • [9] Resveratrol is an inhibitor of sodium-dependent inorganic phosphate transport in triple-negative MDA-MB-231 breast cancer cells
    Lacerda-Abreu, Marco Antonio
    Russo-Abrahao, Thais
    Meyer-Fernandes, Jose Roberto
    CELL BIOLOGY INTERNATIONAL, 2021, 45 (08) : 1768 - 1775
  • [10] Resveratrol Augments Paclitaxel Treatment in MDA-MB-231 and Paclitaxel-resistant MDA-MB-231 Breast Cancer Cells
    Sprouse, Alyssa A.
    Herbert, Brittney-Shea
    ANTICANCER RESEARCH, 2014, 34 (10) : 5363 - 5374